The continuous expansion of biological sciences has completely transformed therapeutic approaches, heavily influencing the growth trajectory of the global plasma fractionation market. Plasma-derived medicines are irreplaceable therapeutic tools for individuals suffering from specialized genetic anomalies, including alpha-1 antitrypsin deficiency and various forms of hemophilia. The critical...